⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
PBM News
Psyence Biomedical Ltd. Common Shares
Psyence BioMed Completes PsyLabs Investment as Ibogaine Milestones Are Met
globenewswire.com
PBM
Psyence BioMed Partners with DEA-Registered Benuvia Operations to Establish U.S. Manufacture of Pharmaceutical-Grade Ibogaine
globenewswire.com
PBM
Psyence BioMed Announces Exclusive U.S. Ibogaine Licence for Texas Ibogaine Research Corporation
globenewswire.com
PBM
Psyence BioMed Announces Strategic Ibogaine Investment
globenewswire.com
PBM
Psyence BioMed Establishes Texas Ibogaine Research Corporation to Advance U.S. Ibogaine Development
globenewswire.com
PBM
Psyence BioMed Welcomes U.S. Administration’s Latest Action to Accelerate Ibogaine Development
globenewswire.com
PBM
Psyence BioMed Announces U.S. Strategic Engagement Initiative Focused on GMP Ibogaine Research and Manufacturing
globenewswire.com
PBM
Pacific Bay Expands Haskins-Reed Critical Minerals Project Near Cassiar, BC Via Option Deal with Eagle Plains Resources Ready to Announce with Confidence?
newsfilecorp.com
PBM
Psyence BioMed Initiates Patient Dosing in Phase IIb Trial Evaluating NPX-5 for Adjustment Disorder
globenewswire.com
PBM
Psyence BioMed Positioned as World's only Licensed Pharmaceutical Grade Ibogaine Supplier at Source
globenewswire.com
PBM